2399 — Biostar Microtech International Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD4.50bn
- TWD3.25bn
- TWD2.34bn
- 23
- 22
- 77
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 66.3 | 182 | 407 | 16.2 | -117 |
Depreciation | |||||
Non-Cash Items | -159 | -204 | -131 | 114 | -7.28 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 380 | -87.7 | -192 | -217 | 147 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 328 | -93 | 91.5 | -80.8 | 29 |
Capital Expenditures | -27.5 | -2.63 | -2.31 | -2.1 | -0.708 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -79.9 | 57.8 | 46 | 378 | -77.7 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -107 | 55.2 | 43.7 | 375 | -78.4 |
Financing Cash Flow Items | -19.6 | -0.022 | 0.001 | 0.07 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -30.1 | -96.9 | -72 | -215 | -1.68 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 167 | -152 | 49.4 | 95.2 | -52.8 |